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RNA viruses replicate with a very high error rate and give rise to
heterogeneous, highly plastic populations able to adapt very
rapidly to changing environments. Viral diseases are thus difficult
to control because of the appearance of drug-resistant mutants,
and it becomes essential to seek mechanisms able to force the
extinction of the quasispecies before adaptation emerges. An
alternative to the use of conventional drugs consists in increasing
the replication error rate through the use of mutagens. Here, we
report about persistent infections of lymphocytic choriomeningitis
virus treated with fluorouracil, where a progressive debilitation of
infectivity leading to eventual extinction occurs. The transition to
extinction is accompanied by the production of large amounts of
RNA, indicating that the replicative ability of the quasispecies is not
strongly impaired by the mutagen. By means of experimental and
theoretical approaches, we propose that a fraction of the RNA
molecules synthesized can behave as a defective subpopulation
able to drive the viable class extinct. Our results lead to the
identification of two extinction pathways, one at high amounts of
mutagen, where the quasispecies completely loses its ability to
infect and replicate, and a second one, at lower amounts of
mutagen, where replication continues while the infective class gets
extinct because of the action of defectors. The results bear on a
potential application of increased mutagenesis as an antiviral
strategy in that low doses of a mutagenic agent may suffice to
drive persistent virus to extinction.
error catastrophe  mutagen  RNA virus  replicative ability 
mathematical model
Rates of spontaneous mutation per genome differ strikinglyamong species, indicating that this character is subjected to
selection and evolutionary change. The optimal mutation rate
results from the need to maintain an accurate enough level of
genetic information while adapting fast to changes in the environ-
ment. Organisms living in constant environments usually display
low mutation rates, whereas organisms thriving in fluctuating
environments need to generate a high genetic diversity. In the latter
case, a complex interaction between the structure of the hetero-
geneous population and the environment ensues (1).
The transmission cycle of RNA viruses in nature includes large
fluctuations in the environment in which replication takes place:
invasion of different organs and tissues, changes of host, pres-
ence of antibodies and molecules secreted by the immune system,
and population bottlenecks, among others. It is believed that the
high mutation rates characteristic of RNA viruses, together with
their short replication time and large populations, favor their
adaptation: rare variants that confer an advantage in a new
environment can become rapidly amplified (2, 3). However, as
described in molecular evolution theories applied to theoretical
genome populations, the mutation rate has an upper limit set by
the requirement of accurate transmission of the genetic infor-
mation (4). When this threshold is crossed, disorganization of the
mutant distribution of the quasispecies occurs, the genetic
information is lost, and the population becomes extinct because
of genetic meltdown. This phenomenon is known as error
catastrophe. The high mutation rate of RNA viruses places viral
quasispecies very close to the error threshold (5, 6), and it has
been experimentally demonstrated that small increases of mu-
tation rate through the use of mutagens can force the extinction
of viral populations (6–15). Classical theories on error catastro-
phe equal fitness to replicative ability and explain extinction on
the basis of the accumulation of many deleterious mutations in
the viral genomes, so that they eventually fail to replicate
themselves. However, if these theories are to be applied to viral
quasispecies, it is necessary to take into account that fitness is not
only determined by the replicative ability of the genomes but also
that there are a number of phenotypic functions that are involved
in the completion of the viral life cycle. The effect of mutations
in all these functions adds extra complexity to the mechanisms
driving viral populations to extinction through increased
mutagenesis.
Within an infected cell, there are many viral genomes sharing
the necessary resources for replication to take place. These
genomes include cellular structures and viral proteins (i.e.,
polymerase and structural proteins of the capsid and envelope).
Because of the high error rates of RNA viruses, even inside a
single cell, the genetic diversity can be very large, because
mutants with a reduced ability to replicate or encode functional
proteins are continuously generated (12). However, as long as
functional products that can act in trans are accessible for any
genome in the cellular interior, there is nothing limiting their use
by defective mutants unable to code for correct proteins them-
selves. This finding means that in a normal infection a variable
amount of the viruses produced are necessarily noninfective.
Inside the cell, the noninfective class can be regarded in practice
as a parasite of the viable type, thus resulting in viable–defector
interactions (16–18) that likely interfere in a deleterious way
with the efficient replication of the altruistic, viable class (19).
Under these circumstances, it seems plausible that many defec-
tive mutants can replicate as fast as viable particles. This finding
is supported by observations made with poliovirus (7–9) and
Hantaan virus (20) where decreases in infectivity preceded
decreases in viral RNA levels. As far as the mutation rate is kept
below a (virus-dependent) critical threshold, noninfective mu-
tants maintain a dynamic equilibrium with fully viable genomes.
Increases in the mutation rate force the appearance of larger
amounts of genomes unable to code for functional proteins
although able to replicate when these proteins are furnished by
other viruses. If the amount of defective particles grows beyond
a critical fraction, it is reasonable to suppose that a form of
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: LCMV, lymphocytic choriomeningitis virus; L, large segment; 5-FU,
5-fluorouracil; VD setting, viable and defective particles are present; V setting, only
viable particles are present.
†Present address: Departamento de Gene´tica, Universidad de Ma´laga, 29071 Ma´laga,
Spain.
To whom correspondence should be addressed. E-mail: cuevasms@inta.es.
© 2005 by The National Academy of Sciences of the USA
4448–4452  PNAS  March 22, 2005  vol. 102  no. 12 www.pnas.orgcgidoi10.1073pnas.0408871102
extinction where defective mutants exhaust functional resources
produced by viable genomes might supervene.
Materials and Methods
Virus and Cells. The genome of lymphocytic choriomeningitis
virus (LCMV) consists of two single-stranded RNA segments:
small segment (S; 3,376 nt) and large segment (L; 7,220 nt) of
negative polarity (21). Virus infections and maintenance of baby
hamster kidney (BHK-21) and Vero cells were carried out as
described (10). LCMV ARM 53b is a triple plaque-purified clone
from ARM CA passaged four times in BHK-21 cells. Virus
infectivity in supernatants and intracellular samples were deter-
mined by assay on Vero cell monolayers because the virus does
not form lytic plaques on BHK-21 cells. Vero cells monolayers
(1  106 cells in six-well dishes, Falcon) were infected in
duplicate with virus suspensions. After 1 h of adsorption, the
virus was removed and cells were overlaid with 4 ml of DMEM
supplemented with 0.7% FCS2% L-glutamine50 g/ml gen-
tamicin0.25% agar. After 84 h, cells were stained with Neutral
red in PBS at a final concentration of 0.25 mg/ml and incubated
for 8 h, and viral plaques were counted.
RNA Amplification, Quantification of the L Genomic Segment, and
Calculation of Mutation Frequencies. Total RNA from samples was
extracted with TRIzol (Invitrogen) and reverse transcription of
the genomic segment L (viral RNA polymerase) was performed
with ThermoScript RT (Invitrogen) at 65°C for 60 min with
primer L4252R (antisense). Amplification by PCR was per-
formed with Pfu (Promega) with primers L3654F (sense) and
L4252R. RNA corresponding to the L genomic segment was
quantified by two-step RT-PCR with the Light Cycler Fast Start
DNA Master SYBR green I kit (Roche Applied Science, Pen-
zburg, Germany) in a Light Cycler instrument (Roche Applied
Science). An LCMV RNA from nucleotides 3654 to 4252 was
used as standard. DNA cloned into pGEM T Easy Vector
(Promega) was transcribed with SP6 DNA polymerase and
purified with RNA Easy minikit (Qiagen, Hilden, Germany).
Molecular clones were obtained by cloning the region encom-
passing nucleotides 3654–4252 into pGEM T Easy Vector
(Promega) and were sequenced with T7 and SP6 promoter
primers. Mutation frequencies were calculated for each virus
sample by comparing the sequences of individual clones with
their corresponding consensus sequence.
Computational Model. Initially, a small number of particles infect
an empty cell. Each virtual viral genome is characterized by two
parameters, the replicative ability r, which takes continuous
values between 1 and R, and the ability to encode viral proteins
correctly, which is a Boolean variable (either yes or no). For
simplicity, we call the genomes viable if the second variable is yes
and defective otherwise. The number of copies produced by a
genome is a random variable drawn from a Poisson distribution
of average r. Replication of the genome, irrespectively of its type,
takes place only if a second randomly chosen genome is of the
viable type. This action mimics the fact that resources are shared
by both types. The effect of the mutagen is represented through
a parameter m, which stands for the average number of muta-
tions per genome and replication. The actual number of muta-
tions for each copy, k, is chosen from a Poisson distribution of
average m. Each mutation has an independent effect (r) on the
replicative ability, with r randomly chosen from an exponential
distribution of average one. The effect of each individual mu-
tation can be deleterious (r  0 with probability p), advanta-
geous (r  0 with probability q), or neutral (r  0 with
probability 1  p  q). The total change r is finally calculated
as the sum of k independent effects. The amount of mutagen also
influences the transition rates between viable and defective
types. The transition from viable to defective types takes place
with probability w whenever r is negative; defective particles
can become viable with probability w if r is positive. This last
rule includes a reasonable correlation between the loss of
replicative ability and a decrease in the capability to code for
proteins correctly. Finally, at each replication cycle and for each
genome, there is a probability d that the genome is eliminated
from the system because of degradation. Once the cell is
infected, error-prone replication proceeds, as described, until a
maximal number of genomes N are reached. When genomes are
in excess, they replace randomly chosen genomes that are
eliminated, thus mimicking virus release by the host cell to the
culture supernatant. For simplicity of the model, neither deg-
radation nor the outgoing flux depends on the replicative ability
or on the viability of the particles.
Results
To study the effect of increased mutagenesis in the production
of noninfective genomes, we have carried out several in vitro
experiments with the prototypic Arenavirus LCMV. We have
monitored infective virus production and the amount of L RNA
genomic molecules during a virological steady-state persistent
infection of BHK-21 cells by LCMV in the absence and presence
of 100 gml of the mutagenic base analogue 5-fluorouracil
(5-FU). The quantification of infective units and L RNA mol-
ecules was made separately in the cell culture supernatant
(viruses released by the cell) and in the cellular monolayers. In
the course of the infection, there is a clear increase in the number
of genomic RNA molecules, both in the intracellular fraction and
in supernatants of control and mutagenized virus (Fig. 1).
However, in FU-treated virus cultures at 48 h after infection,
infectivity declines and falls below detection, despite the high
number of genomic RNA molecules attained. At 72 h after
infection, there are 100 times more RNA molecules in the
control than in the mutagenized sample (Table 1). Interestingly,
the ratios are much more dramatic for the number of infective
units. In the control sample (either in the intracellular fraction
or in the supernatant), there is between 105- and 106-fold larger
number of infectious units than in the mutagenized sample. The
ratio between total RNA molecules and infective units grows
almost exponentially when the population approaches extinc-
tion. These results indicate that, in the presence of 5-FU,
replication of LCMV RNA molecules is affected to a much lower
extent than infectivity, and clearly demonstrates that the relative
production of nonviable particles dramatically raises with an
increase in the mutation rate.
To analyze the effect of the mutagen on the error rate of viral
replication, the accumulated number of mutations in 20 viral
genomes at different times after infection was determined. To
this end, we cloned and sequenced a region of the L gene both
from intracellular and supernatant fractions in mutagenized and
control populations (see Materials and Methods). For control
viruses, mutation frequency values were in the range of 1.2 to
3.5  104 substitutions per nucleotide. In 5-FU-treated sam-
ples, the mutation frequency varied between 1.0  104 and
1.8 103. Whereas in the intracellular fraction of mutagenized
viruses, we find a statistically significant trend to increase the
mutation frequency with the time of exposure to FU, the
regression analysis does not show a significant positive trend in
the supernatant fraction. This finding indicates that, at least
within the cellular environment, the action of the mutagen keeps
the system out of the mutation-selection equilibrium, eventually
resulting in extinction of infectivity.
The representation of the number of infective units per RNA
molecule as a function of the mutation frequency (Fig. 2) yields
a curve with a sharp decay when the mutation frequency
increases past a critical threshold (6). This sudden loss of
infectivity takes place through a transition analogous to that
predicted by error catastrophe theory. However, the unexpected
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outcome of the experiment is the presence of large numbers of
RNA molecules, revealing that the replicative ability does not
disappear simultaneously with the infectivity.
Our results so far seem to support the initial statement that an
enhanced presence of defective replicators might cause the
extinction of a viable (infective) class. Ideally, we would like to
repeat the same experiment in the absence of defective genomes
and with a mutagenic agent affecting only the replicative ability
of the virus. This experiment cannot be carried out with real
viruses because of the intrinsic impossibility of separating de-
fective from infective genome populations. At this point, how-
ever, suitable in silico experiments can fill this gap and illustrate
the qualitative behavior to be expected in such a situation (see
Materials and Methods). With the goal of proving that, in the
computational model, extinction is induced by the action of
defective genomes, two different settings are considered. In the
first one, both viable and defective particles are present (VD
setting). In the second one, all genomes are viable and the
mutagen only acts on their replicative ability, that is, on the
number r of copies produced per genome (V setting).
The dynamics of the process in both settings is represented in
Fig. 3. The two settings, VD and V, display a qualitatively
different dynamical behavior at low concentration of mutagen
(Fig. 3A), whereas they behave similarly for high values ofm (Fig.
3B). For relatively large amounts of mutagen, setting V or setting
VD, experience the effect of mutagen in a similar way: replica-
tion is strongly impaired and the initial population goes readily
extinct. In most computer simulations, defective particles with
r  0 never appeared. This scenario changes for lower amounts
of mutagen, where a persistent coexistence of both types be-
comes possible in the VD setting. Then, the typical time required
for disappearance of all viable particles increases many fold,
although eventual extinction is unavoidable. This situation con-
Fig. 1. Quantification of the L genomic segment in the extinction of LCMV.
Infectivity of virus in supernatants and cell fractions of LCMV incubated in the
absence (A, control) or presence of 100 gml 5-FU (B) were assayed on Vero
cell monolayers. ic, intracellular; sn, supernatant. Total RNA from these sam-
ples was extractedwith TRIzol (Invitrogen) and the RNA corresponding to the
Lgenomic segmentwasquantifiedby two-stepRT-PCRwith theFast StartDNA
Master SYBR green I kit (Roche Applied Science) in a Light Cycler instrument
(Roche Applied Science). Virus titers (circles) and RNA (squares) are expressed
as total plaque-forming units and total molecules of L genomic RNA, respec-
tively, for each sample. Error bars for selected points correspond to 1 SD from
the average.
Table 1. Ratios of RNA and plaque-forming unit abundance between the controls and the
FU-treated samples (data are in Fig. 1).
Time after
infection, h
Ratio of total RNA
molecules (sn)
Ratio of total RNA
molecules (ic)
Ratio of
pfu (sn)
Ratio of
pfu (ic)
0 — 0.232 0.39 0.14
24 29.4 2.441 2.88  103 2.24  103
48 264.7 129.4 2.19  105 2.85  104
72 60.9 56.74 5.50  106 6.33  105
sn, supernatant; ic, intracellular.
Fig. 2. Relation between infectivity and mutation frequency for infections
in the presence of 5-FU. Infectivity values (plaque-forming units per RNA
molecule) were calculated by using the results of Fig. 1. The mutation fre-
quency was determined after sequencing the region encompassing nucleo-
tides 3654–4233. There is a criticalmutation ratebeyondwhich infectivitygets
extinct. For the intracellular fraction of mutagenized samples, a number
between 13 and 25 sequences was analyzed. The corresponding standard
deviation for the mean number of mutations per sequence (SD) lies between
0.41 and 0.92. For supernatant fractions ofmutagenized samples, the number
of sequences analyzed varied between 7 and 15 (SD values between 0.38 and
1.20). In the control intracellular samples, we analyzed 13–15 sequences (SD
values between 0.27 and 0.41). For control supernatant fractions, 20 se-
quences were analyzed at 24 h after infection in the intracellular fraction
(SD  0.31) and 19 sequences at 72 h after infection (SD  0.54).
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trasts strongly with the dynamical behavior of setting V: for
amounts of mutagen lower than the critical value forbidding
replication (mc), extinction of the population has never been
observed. Thus, in the absence of defectors, extinction does not
occur once the total number of particles becomes large enough.
Taking m as independent variable, we have monitored the
average behavior of several relevant quantities (Fig. 4). Whereas
in the V setting extinction is possible only above the critical error
threshold mc, the two different dynamical regimes in the VD
setting represent two different pathways to extinction: as in the
V setting, extinction takes place when the error rate in replica-
tion is above the critical error rate (m  mc), but a second
pathway to extinction appears below that threshold because of
lethal defection (mmc). In the presence of defective genomes,
the system is doomed to extinction.
Discussion
The high sensitivity of LCMV to FU (10, 15) and the steady-state
persistent infection that the virus establishes in BHK-21 cells
(22) permits monitoring of intracellular and extracellular LCMV
RNA and infectivity without confounding effects of cell killing
and RNA release inherent to cytolytic infections or persistently
infected, carrier cultures.
The empirical observations, together with the numerical re-
sults, suggest that, in the experiments, it is the presence of
defectors which induces extinction at moderate concentrations
of mutagen. An additional constraint is essential to observe
extinction: that the system size be finite because, as N grows, the
average time to extinction increases as well, and eventually
diverges for an infinite system. Another difference between the
settings V and VD is the nature of the transition between the two
dynamical regimes. In the setting without defectors, there seems
to be a discontinuity at m  mc, where the time to extinction
jumps from finite (and small) values to infinity. In contrast, the
transition for VD seems to be continuous, with the extinction
time growing smoothly once the amount of mutagen is low
enough to permit the coexistence of viable and defective ge-
nomes. The qualitative behavior displayed in Figs. 3 and 4 is
robust with respect to changes in the values of the parameters
and rules of the model, as long as the separation of the effects
of mutations in replication and viability is included.
The intrinsic dynamics of the process in the pathway to
extinction because of the action of defectors (m  mc) is highly
fluctuating. This is because of the multiplicative nature of the
replicative process and to the stochastic appearance of mutants.
Fig. 3. Dynamics of the model system at low and high amounts of mutagen
m, illustrating the two different pathways to extinction. (A) Extinction due to
the action of defectors. The curves show the number of genomes inside a
model cell in the VD and V settings (with VD genomes or only V genomes,
respectively), form 6mutations per genome and replication cycle. In the VD
setting, the total numberofgenomes (VD, full line)fluctuatesbroadlybecause
of the decoupling between replicative ability and viability for each genome,
which translates into a variable amount of V genomes (dashed line). Once V
genomes disappear, replication is no longer possible, and the extinction of
unviable (although replicative) genomes follows. In the V setting (lower plot),
high numbers of viable genomes are maintained and extinction is not ob-
served. (B) Extinction due to the loss of the replicative ability. At high amounts
of mutagen (m  20 in these plots), viability and replicative ability are
simultaneously lost, extinction occurs readily, and no qualitative difference
between the VD and V settings is observed. Time is measured in replication
cycles. All simulations start with 10 viable particles of replicative ability r 2.
Other parameters values are P 0.9, q 0.05, R 4, d 0.02, andw 0.5 for
the setting VD.
Fig. 4. Statistical behavior of the model system as a function of the average
number of mutations per copy (m, horizontal axis). Two different regimes
separated by the vertical dotted line at the critical amount of mutagenmc 
15 can be distinguished. (A) Average time to extinction. Diamonds stand for
the V setting (with viable genomes only), stars stand for the VD setting (with
VD genomes). In the V setting, there is no extinction for m  mc; in the VD
setting, extinction occurs in finite time for any value of m. Above the critical
value mc, both settings behave similarly, and extinction takes place in a few
hundred replication cycles. (B) Average number of genomes present until
extinction supervenes. Open squares correspond to the V setting. There is a
clear transition from a full system to only few genomes present at m  mc.
Solid symbols correspond to the VD setting. Defective (triangles) and V ge-
nomes (circles) coexist before extinctionoccurs in thephasemmc. Above the
transition, the behavior is comparable to the system without defective ge-
nomes (V). (C) Average replicative ability of the genomes (symbols are as in B).
In all cases, the replicative ability of the genomes decreases monotonously
with the increase in the amount of mutagen. In the VD setting, and for m 
mc, defective genomes appear only rarely, and the average fitness of the
viable genomes is just that of the initial population. The average replicative
abilityof thedefective type lies alwaysbelowthatof theviable type, this being
the result of the correlation between positivenegative changes in replicative
ability and gainloss of viability. In all images, each point represents an
average over several thousand independent numerical simulations of the
system. Parameter values are as in Fig. 3.
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The system is highly sensitive to the events occurring at the initial
steps of growth, which can determine whether extinction occurs
readily and before the number of particles is large enough to
settle the system. Later, the number of viable particles, which
determines the sustainability of the entire system, is hardly
affected by the contingent appearance of defective mutants. As
a consequence, it is not possible in practice to establish with a
high degree of accuracy the moment at which extinction occurs,
in agreement with previous experiments (10).
The position of the error threshold and the pathway leading to
extinction are not only determined by the mutation rate. Virus
infection comprises more processes than genome replication
and, because these processes can also be affected by mutations,
they must be taken into account (3, 6). This situation can become
more complex when the error threshold at which genotypic
information is lost differs from that at which phenotypic infor-
mation disappears (23), or when phenotypic traits experiencing
different selective pressures in two environments are coupled
through fitness tradeoffs (24).
Our conceptual framework includes phenotypic characteris-
tics, such as the ability to encode proteins, as a relevant fact
affecting the dynamics and fate of heterogeneous populations.
We have only distinguished between viable and defective ge-
nomes as those able or not to code for the functional proteins
necessary for virus completion. However, in a viral infection it
is expected to obtain genomes with different abilities to code for
products or, in other words, viral particles with different degrees
of infectivity. In a natural system, there will also be genomes that
lack the signals for interacting with the polymerase or for
encapsidation. These viruses will not further replicate and will be
eliminated from the system. Taking into account these other
properties, not explicitly considered in our model, implies that
our numerical results probably underestimate the fraction of
defective genomes present. In addition, it seems plausible that
when fitness is separated in a number of essential traits that
experience differential selection in a certain environment, there
will be as many pathways to extinction (or extinction thresholds)
as traits considered. If, moreover, the disappearance of one of
the traits implies the extinction of a second one (as is the case
here, where the extinction of viability forbids further replica-
tion), a cascade of effects triggered with the extinction of the first
trait is to be expected. In practice, it might prove difficult to
disentangle direct effects because of the action of external forces
(like the mutagen) from indirect effects because of the disap-
pearance of a particular but essential trait.
Another consequence of the mechanism just described is that
a (potentially viable) population may contain infective genomes
that are nevertheless unable to replicate just because of the
interfering effect of deleterious mutants. In this sense, the
occurrence of bottlenecks can be decisive to avoid extinction by
aiding to isolate genomes that are able to initiate an infection
(25, 26). From this point of view, bottleneck events would be a
kind of positive selection operating against extinction caused by
increases in the mutation rate. These results confer new and
renewed biological implications to the defective viral genomes
that coexist with viable counterparts, implications that faded
after the studies with defective interfering particles three de-
cades ago. This finding comes at a time in which error-prone
replication, cellular and viral genome plasticity, and limited
accuracies in cellular processes are becoming the rule rather than
the exception. Finally, the results imply that a modest mutagenic
activity to increase the level of viral genome defectors may be
sufficient to effect viral extinction, thus facilitating a possible
clinical application of viral extinction through lethal defection.
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